International Nonproprietary Names (INNs) provide a unique name for each pharmaceutical substance to aid clear identification and safe use worldwide. The WHO manages the INN system, selecting names through a process involving proposed names, an objection period, and final recommended INNs. INNs aim to identify substances uniquely while avoiding names that could cause confusion or be proprietary. Principles for selection include being distinctive, concise, and avoiding confusion with other names. Stem elements are often used to group related substances.
Establishment of Pharmacovigilance ProgrammeNipun Gupta
1. Pharmacovigilance
2. Pathway of PvPI
3. Establishment of PV Programme
in Hospital
4. Establishment of PV Programme
in Industry
5. Contract Research Organization
6. Establishment a National Programme
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Definitions, Severity assessment, Seriousness assessment
Naranjo algorithm, Preventability assessment
By
Ms. B. Mary Vishali
Department of Pharmacology
Establishment of Pharmacovigilance ProgrammeNipun Gupta
1. Pharmacovigilance
2. Pathway of PvPI
3. Establishment of PV Programme
in Hospital
4. Establishment of PV Programme
in Industry
5. Contract Research Organization
6. Establishment a National Programme
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Definitions, Severity assessment, Seriousness assessment
Naranjo algorithm, Preventability assessment
By
Ms. B. Mary Vishali
Department of Pharmacology
This presentation gives a brief knowledge of CIOMS, its history, missions and collaborations of CIOMS. This presentation also contains CIOMS organizational structure, detailed knowledge of CIOMS Former and Present Working Groups. This will also guide about CIOMS form, its reporting and details to be filled while reporting an ADR.
detection methods of Adverse drug reactions, postal survey method, Reporting of Adverse drug reactions, Preventability assessment, predictability assessments
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...Dr.Amreen Saba Attariya
detailed information about Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilisation, DU90%, WHO Collaborting Centre for drug statistic methodology, DDD/1000inhabitants/day, DDD/100beddays, DDD/1000inhabitants/year, Pediatric DDD, ATC & DDD in drug utilisation research, Electronic Prescribing, Guidelines for ATC classification & DDD assignment 2016
Organization and objectives of ICH, expedited reporting, ICSR, PSURs, post approval expedited reporting, pharmacovigilance Planning, good clinical practices
Concept of Pharmacovigilance, history and development of pharmacovigilance, WHO International drug monitoring programme, Pharmacovigilance programme of India
This presentation gives a brief knowledge of CIOMS, its history, missions and collaborations of CIOMS. This presentation also contains CIOMS organizational structure, detailed knowledge of CIOMS Former and Present Working Groups. This will also guide about CIOMS form, its reporting and details to be filled while reporting an ADR.
detection methods of Adverse drug reactions, postal survey method, Reporting of Adverse drug reactions, Preventability assessment, predictability assessments
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...Dr.Amreen Saba Attariya
detailed information about Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilisation, DU90%, WHO Collaborting Centre for drug statistic methodology, DDD/1000inhabitants/day, DDD/100beddays, DDD/1000inhabitants/year, Pediatric DDD, ATC & DDD in drug utilisation research, Electronic Prescribing, Guidelines for ATC classification & DDD assignment 2016
Organization and objectives of ICH, expedited reporting, ICSR, PSURs, post approval expedited reporting, pharmacovigilance Planning, good clinical practices
Concept of Pharmacovigilance, history and development of pharmacovigilance, WHO International drug monitoring programme, Pharmacovigilance programme of India
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit testssaimuniswetha1
Today's Topic Pharmacopoeias, Sources of Impurities in Medicinal agents and Limit tests for Chlorides, Sulphates, Heavy Metals, Lead, Iron in Pharmaceutical Analysis subject for B.pharmacy 1st year as per JNTUA Syllabus...
This is to deal with UG Pharmacology entry label practical To know what are the various sources of drug information.
To select the appropriate source depending on the information.
To discuss briefly the role of electronic media in medicine.
history of pharmacy, pharmacopoeia, british pharmacopoeia, ameracan pharmacopoeia, pharmaceutical codex, formularis, chemical professionals code of conduct.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
How to Split Bills in the Odoo 17 POS ModuleCeline George
Bills have a main role in point of sale procedure. It will help to track sales, handling payments and giving receipts to customers. Bill splitting also has an important role in POS. For example, If some friends come together for dinner and if they want to divide the bill then it is possible by POS bill splitting. This slide will show how to split bills in odoo 17 POS.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
2. INTRODUCTION:
• An International Nonproprietary Name (INN) identifies a pharmaceutical substance
or active pharmaceutical ingredient by a unique name that is globally recognized
and is public property.
• A nonproprietary name is also known as a generic name.
• The INN system was managed by WHO.
2
3. HISTORYOFINNs:
• The INN system was initiated in 1950 by a World Health Assembly
resolutionWHA3.11
• It began operating in 1953
• The cumulative list of INNs now contains 9300 names, and this number is growing
every year by some 160 new INNs.
3
4. AIMOFINNSSYSTEM:
• To provide health professionals with unique name to identify each pharmaceutical
substance
• Aim to clear identification, safe prescription and dispensing of medicines to
patients,
• For communication and exchange of information among health professionals and
scientists worldwide.
• Non proprietary names are intended for use in pharma, labelling, product
information, advertising and other promotional material
4
5. TRADENAMES:
Trade Names:
• Most products available on the market are now a days advertised, promoted, and
identified by a trade name.
• Trade names are usually selected by the owner of the product and registered in
national trademark or patent offices.
• They are private property and can be used only with the consent of the owner of
the trademark
• Example: Dolo-650
5
6. SELECTIONOFINN
• The INN are selected by the world Health Organization on the advice of experts
from the WHO Expert Advisory Panel on the International Pharmacopoeia and
Pharmaceutical Preparations.
• The process of INN selection follows three main steps:
• A request/ application is made by the manufacturer or inventor to WHO
secretariat
• After a review of the request a proposed INN is selected and published for
comments for objection for 4 months
• After completion of 4 months the proposed INNS is finalized and published as
recommended INNs , which is the final name of substances, which cannot be
changed throughout life.
6
7. CONTD..
• Since the name is available in the public domain it may be used freely. However, it
should not be registered as a trade-mark since this would prevent its use by other
parties.
• INN is designated for the active part of the molecule only, to avoid the
multiplication of entries in cases where several salts, esters, etc. are actually used.
• In such as cases , the user of the INN has to create a modified INN(INNM).
• Ex: mepyramine maleate ( a salt of mepyramine with maleic acid)
7
9. PROPOSEDINNs:
• Proposed INNS are list of drug substances which under objection period
• Newly selected, proposed INNs are then published in WHO Drug Information,
which indicates a deadline for a 4-month objection period
• This period is allowed for comments and/or objections to the published names
to be raised.
• The reasons for any objection must be stated clearly and these will be evaluated
by the experts for further action
• Two lists of proposed INNs are published yearly
9
10. RECOMMENDED INNs
• The final stage of the selection process is the recommended INN.
• Once a name has been published as a recommended INN it will not normally be
modified further and is ready for use in labeling, publications, on drug information.
• It will serve to identify the active pharmaceutical substance during its lifetime
worldwide.
• Recommended INNs are published in the WHO Drug Information as a
consequence of the objection procedure applied to proposed INNs
• As from 1997, two lists of proposed INNs are published yearly and as from list 37
of recommended INNs with its graphic formulae are selected.
10
12. MODIFIEDINNMs:
• If a "radical and group name" is used in conjunction with an INN, they are referred
to as International Nonproprietary Name (Modified) or INNM.
• For example, oxacillin and ibufenac are INNs and their salts are named oxacillin
sodium and ibufenac sodium. The latter are called modified INNs (INNMs).
• for radicals and groups which are used in conjunction with INNs and which are also
referred to as INNM, and the document International Nonproprietary Names
Modified, INN Working Document 05.167/3.
12
13. CUMULATIVELIST:
• All names selected as proposed and recommended INNs are published in a
Cumulative list, which is updated periodically.
• The generic names are presented in alphabetical order by Latin name
Each entry includes:
• equivalent nonproprietary names: : in Latin, English, French, Spanish, Arabic,
Chinese and Russian, as well as reference to other common names
• a reference to the INN list in which the name was originally proposed or
recommended, or last amended;
• reference to names of substances that have been abandoned or never been
marketed;
• reference to national nonproprietary names;
• reference to pharmacopeial monographs or similar official references;
13
14. • reference to names issued by the International Organization for Standardization
(ISO);
• reference to the Convention of Psychotropic Substances, if applicable;
• reference to the List of Narcotic Drugs under International Control, if applicable;
• the molecular formula;
• its Chemical Abstracts Service (CAS) number.
14
16. The primary principles for selection:
• Distinctive in sound and spelling
• Not too long; and
• Not liable to confusion with other names in common use.
Ex: ac: anti-inflammatory agents, ibufenac derivatives
- Coxib for COX-2 inhibitors, a type of anti-inflammatory drugs ( e.g. celecoxib)
• Do not select names for mixtures of substances
• Do not select for herbal substances ( vegetable drugs) or for homoeopathic
products.
• Do not select names for those substances that have a long history of use for
medical purposes under well-established names such as those of alkaloids ( e.g.
morphine, codeine) , or trivial chemical names ( e.g acetic acid)
16
17. USEOFSTEMS:
• Usually, an INN consists of a random, fantasy prefix and a common stem;
• substances belonging to a group of pharmacologically related substances show
their relationship by the use of a common stem.
• e.g. olol for -adrenoreceptor antagonists and antihypertensive, -teplase for tissue-
type-plasminogen activators activators.
• A list of common stems used in the selection of INNs may be found in Annex 3.
17
18. STEREOISOMERS
• Steric characteristics of the chemical names(S) are indicated by using specific
prefixes.
• For a different enantiomer or for the racemic form of the compounds, the
following prefixes should be added to the existing INN:
a) For the levo form, the lev-/levo- prefix is used,
e.g. levocarnitine, levamisole.
b) For the dextro form, the dex- prefix is used,
e.g. dexamisole, dexibuprofen.
c) For the racemic form, the rac-/race- prefix is used,
e.g. racepinefrine
18
19. RADIOACTIVE ISOTOPES:
A name for a drug substance containing a radioactive atom should list, in the
following order:
1) the name of the substance containing the radioactive atom,
2) the isotope number,
3) the element symbol, and
4) the name of the carrier agent, if any,
• e.g. cyanocobalamin (60 Co), technetium ( 99m Tc) bicisate, technetium ( 99m Tc)
sestamibi.
19
20. SPECIFICGROUPSOFBIOLOGICAL
SUBSTANCES
• specific groups of biological substances names were assigned to antibiotics,
synthetic peptides, hormones and other proteins.
• Example:
• Insulin human was proposed for the recombinant protein and it was first
recommended recombinant protein
• New stems for – tissue plasminogen activators - plase
• for naming monoclonal antibodies- they use stem – mab
• Within the INN Programme, names have not been assigned to natural human blood
products or vaccines.
• For those groups of biological products, the WHO Expert Committee on Biological
Standardization (ECBS) has been adopting the scientific names of the biological
products within the definitions of respective requirements.
20
21. PROTECTIONOFINN
• WHO Expert Committee recommended
• “Enact rules or regulations, as necessary, to ensure that international
nonproprietary names.. Should be protected
• Develop policy guidelines on the use and protection of international
nonproprietary names, and to discourage the use of names derived from INNs,
and particularly names including INN stems in trademarks”
21
22. USEOFINNsININDIA:
• In india, section 13 ( b) of the Trade Marks Act, 1999 prohibits the registration of
names of chemical elements or INNs which have been declared by the World
Health Organization ( WHO) and notified by the Registrar of Trade Marks.
• The WHO has brought the same to the attention of the Drug Controller General of
India.
• Use of INNs to coin brand names
• INN- vinleurosine Stem- osine Brand name- Virosine DR company-
Ranbaxy
22
23. PREVENTIONOFREGISTRATIONOFCERTAIN
TRADEMARKSBYSOMEINDIANCOMPANIES:
• The WHO demanded that the applications for registration of brand names, like
Tiotrop, Guapride, Dipride and Pride by companies Sun Pharma, Ajanta pharma,
Divus Lab and First care pharma respectively should not be entertained.
• Also, WHO asked the DCGI to prevent approval of brand names Riluzole by Rajvi
Vipul Bhagat, Mumbai as Riluzole is an INNs
23
24. REFERENCES:
• Guidance on International nonproprietary names for Pharmaceutical Substances by WHO
• International Non proprietary names by P.Ilanangai, IP consultant, Patent Department.
24